Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ISRCTN17427081) titled 'Using the Huangqi-Baizhu formula to manage chronic obstructive pulmonary disease' on Dec. 9.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Condition:
Chronic obstructive pulmonary disease
Respiratory
Intervention:
Utilizing a Target Trial Emulation (TTE) design on real-world data (Jan 2019-Dec 2024) from four Chinese tertiary hospitals, this study evaluates HBF effect on 1-year readmission risks. To mitigate confounding from concomitant herbs, the analysis employs PCA and UMAP dimensionality reduction. De-iden...